Готові списки джерел за темами / Medicine, Chinese

Добірка наукової літератури з теми "Medicine, Chinese"

Автор: Grafiati
Опубліковано: 4 червня 2021
Оновлено: 30 липня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Medicine, Chinese".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Medicine, Chinese"

1

Xue, Charlie Changli, and David Story. "Chinese Medicine in Australia." Asia-Pacific Biotech News 08, no. 23 (December 2004): 1252–56. http://dx.doi.org/10.1142/s0219030304002137.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Yang, Bo, Yun Xie, Maojuan Guo, Mitchell H. Rosner, Hongtao Yang, and Claudio Ronco. "Nephrotoxicity and Chinese Herbal Medicine." Clinical Journal of the American Society of Nephrology 13, no. 10 (April 3, 2018): 1605–11. http://dx.doi.org/10.2215/cjn.11571017.

Повний текст джерела
Анотація:
Chinese herbal medicine has been practiced for the prevention, treatment, and cure of diseases for thousands of years. Herbal medicine involves the use of natural compounds, which have relatively complex active ingredients with varying degrees of side effects. Some of these herbal medicines are known to cause nephrotoxicity, which can be overlooked by physicians and patients due to the belief that herbal medications are innocuous. Some of the nephrotoxic components from herbs are aristolochic acids and other plant alkaloids. In addition, anthraquinones, flavonoids, and glycosides from herbs also are known to cause kidney toxicity. The kidney manifestations of nephrotoxicity associated with herbal medicine include acute kidney injury, CKD, nephrolithiasis, rhabdomyolysis, Fanconi syndrome, and urothelial carcinoma. Several factors contribute to the nephrotoxicity of herbal medicines, including the intrinsic toxicity of herbs, incorrect processing or storage, adulteration, contamination by heavy metals, incorrect dosing, and interactions between herbal medicines and medications. The exact incidence of kidney injury due to nephrotoxic herbal medicine is not known. However, clinicians should consider herbal medicine use in patients with unexplained AKI or progressive CKD. In addition, exposure to herbal medicine containing aristolochic acid may increase risk for future uroepithelial cancers, and patients require appropriate postexposure screening.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Janovská, D., K. Kubíková, and L. Kokoška. "Screening for antimicrobial activity of some medicinal plants species of traditional Chinese medicine." Czech Journal of Food Sciences 21, No. 3 (November 18, 2011): 107–10. http://dx.doi.org/10.17221/3485-cjfs.

Повний текст джерела
Анотація:
The antimicrobial activity of crude ethanolic extracts of 10 medicinal plants used in traditional Chinese medicine was tested against five species of microorganisms: Bacillus cereus, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Of the 10 plants tested, 5 showed antimicrobial activity against one or more species of microorganisms. The most active antimicrobial plants were Chelidonium majus, Sanguisorba officinalis, and Tussilago farfara.  
Стилі APA, Harvard, Vancouver, ISO та ін.
4

OES, Valdeolla. "Same and Different to Clinic Diagnosis in Chinese Traditional Medicine and Ayurvedic Medicine." Journal of Natural & Ayurvedic Medicine 8, no. 1 (January 17, 2024): 1–4. http://dx.doi.org/10.23880/jonam-16000443.

Повний текст джерела
Анотація:
Rationale: Diagnosis is an important part of the field of medicine in general and natural and traditional medicine in particular. In our country, the process of diagnosing diseases in natural and traditional medicine is carried out in different ways. These include diagnosis by traditional Chinese medicine and Ayurveda medicine. Between both types of medicines there are common aspects, but at the same time different aspects; However, these characteristics are little known by health professionals. Method: A bibliographic review was carried out on the particularities of the diagnosis between traditional Chinese medicine and Ayurveda medicine with the aim of showing the elements that are similar and at the same time different. Books, pamphlets and articles on the subject were reviewed. Results: The elements that are similar for the diagnosis between both medicines and at the same time those that are different are presented. Conclusion: Knowledge of the common and different aspects in the diagnostic process between both medicines will allow the interested party to go deeper into determining the disease for subsequent treatment.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Shi, Yucong, Dan Chen, Shengsuo Ma, Huachong Xu, and Li Deng. "Identification of Potential Biomarkers of Depression and Network Pharmacology Approach to Investigate the Mechanism of Key Genes and Therapeutic Traditional Chinese Medicine in the Treatment of Depression." Evidence-Based Complementary and Alternative Medicine 2021 (December 31, 2021): 1–14. http://dx.doi.org/10.1155/2021/2165632.

Повний текст джерела
Анотація:
Background. To explore the potential target of depression and the mechanism of related traditional Chinese medicine in the treatment of depression. Method. Differential gene expression in depression patients and controls was analyzed in the GEO database. Key genes for depression were obtained by searching the disease databases. The COREMINE Medical database was used to search for Chinese medicines corresponding to the key genes in the treatment of depression, and the network pharmacological analysis was performed on these Chinese medicines. Then, protein-protein interaction analysis was conducted. Prediction of gene phenotypes was based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment scores. Results. The total number of differentially expressed genes in the GEO database was 147. Combined with the GEO dataset and disease database, a total of 3533 depression-related genes were analyzed. After screening in COREMINE Medical, it was found that the top 4 traditional Chinese medicines with the highest frequency for depression were Paeonia lactiflora Pall., Crocus sativus L., Bupleurum chinense DC., and Cannabis sativa L. The compound target network consisted of 24 compounds and 138 corresponding targets, and the key targets involved PRKACA, NCOA2, PPARA, and so on. GO and KEGG analysis revealed that the most commonly used Chinese medicine could regulate multiple aspects of depression through these targets, related to metabolism, neuroendocrine function, and neuroimmunity. Prediction and analysis of protein-protein interactions resulted in the selection of nine hub genes (ESR1, HSP90AA1, JUN, MAPK1, MAPK14, MAPK8, RB1, RELA, and TP53). In addition, a total of four ingredients (petunidin, isorhamnetin, quercetin, and luteolin) from this Chinese medicine could act on these hub genes. Conclusions. Our research revealed the complicated antidepressant mechanism of the most commonly used Chinese medicines and also provided a rational strategy for revealing the complex composition and function of Chinese herbal formulas.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Esposito, Bruce J., Manfred Porkert, Christian Ullman, and Mark Howson. "Chinese Medicine." Pacific Affairs 62, no. 2 (1989): 246. http://dx.doi.org/10.2307/2760588.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ahmed, Bilal, and Aatiqa Ali. "Usage of traditional Chinese medicine, Western medicine and integrated Chinese-Western medicine for the treatment of allergic rhinitis." Science Progress and Research 1, no. 1 (January 1, 2021): 1–10. http://dx.doi.org/10.52152/spr/2021.101.

Повний текст джерела
Анотація:
The research examines the differences between populations and medical applications of allergic rhinitis patients who received all three treatments to determine the use of different drugs. Methods: The inventory for patients diagnosed with allergic rhinitis (International Disease Classification). The Chi-square test and Tukey test were performed for the region of interest to check the disparity between these three treatments (a significant difference still exists). The interview rate for women with allergic rhinitis is higher than for men regardless of whether it is treatment with traditional Chinese medicine, Western or combined traditionalChinese and Western medicine.Traditional Chinese medicine includes medical measures with maximum hours per person, the daily cost per hour of medicines and minimum overall hourly expenditure. Western medicine, by comparison, costs the lowest daily drug per hour, and the highest total drug costs per hour per person. Between traditional Chinese and western medicine, the total cost per capita of integrated traditional Chinese and Western Medicine as well as drug costs per capita and the total cost per capita. Although only 6.82% of allergic rhinitis patients opt for combinedtraditional Chinese medicines and western medicine, their rate of receipt is higher each year.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Liu, Shihui, Toshihiko Matsuo, Chie Matsuo, and Takumi Abe. "Traditional Chinese Medicines and Prescriptions Brought from China to Japan by a Monk (Jianzhen, Japanese: Ganjin): A Historical Review." Compounds 2, no. 4 (October 18, 2022): 267–84. http://dx.doi.org/10.3390/compounds2040022.

Повний текст джерела
Анотація:
(1) Background: Japanese Kampo medicine has its origin in ancient Chinese medicine. In 742, a Tang Dynasty monk named Jianzhen (Ganjin) was invited by Japanese clerics to visit Japan and teach commandments in Buddhism. Because of the dangers of the voyage and also other obstacles, he took 11 years to reach Japan on the sixth voyage and he was blind when he arrived in Japan. He was the first person in China to go to Japan to establish the Buddhism commandments, and he was also the first person in Japan to directly teach traditional Chinese medicine. Until now, there have been few reports in English about the details of the Chinese herbal medicines he brought to Japan, including the types of herbal medicines, pharmacological activities, and formulations. In the review, we systematically and comprehensively summarized Jianzhen’s life from the standpoint of his medical and pharmaceutical knowledge and the types and pharmacological activities of Chinese herbal medicines and prescriptions that were brought to Japan by Jianzhen; (2) Methods: A review was made on the relevant literature written by Chinese, Japanese, and English languages regarding the medical and pharmacological knowledge of Jianzhen, the 36 Chinese herbal medicines brought to Japan by Jianzhen, and the pharmacological and therapeutic effects of these 36 herbal medicines, as well as their formulations; (3) Results: The review of the literature proved that Jianzhen’s prescriptions served as a basis for current herbal medicines (Kampo) in Japan. In the process of the literature search, we found a book entitled Jianshangren (Holy Priest Jianzhen)’s Secret Prescription, which recorded the complete prescription of the 36 traditional Chinese medicines Jianzhen brought to Japan; (4) Conclusions: Jianzhen is one of the ancestors of traditional Chinese medicine/Kampo medicine, and he brought traditional Chinese medicine and medical books to Japan for patients. He made important contributions to the development of traditional Chinese medicine in Japan.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Guo, Shizhan, Xiaomeng Li, and Ziyang Liu. "Planting Chinese Herbal Medicine to Inherit the Development of Chinese Medicine Culture under the Background of Rural Revitalization: Taking Jiujianfang in Lantian County as an Example." Modern Management Science & Engineering 6, no. 1 (May 3, 2024): p73. http://dx.doi.org/10.22158/mmse.v6n1p73.

Повний текст джерела
Анотація:
Along with the development of the times, Chinese medicine has gradually integrated into the mainstream of people's healthy life, and it has become the general trend of the current society to inherit the development of traditional Chinese medicine. Based on the investigation and analysis of planting bases, planting methods, planting conditions and varieties of Chinese herbal medicines in Jiujianfang area of Lantian County, we should bring the advantages of Chinese herbal medicine cultivation into full play and promote the cultural inheritance of Chinese medicine, Open up new ideas for the future development of traditional Chinese medicine and further promote rural revitalization.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Li, Lu, Ping Chung Leung, Tony Kwok Hung Chung, and Chi Chiu Wang. "Systematic Review of Chinese Medicine for Miscarriage during Early Pregnancy." Evidence-Based Complementary and Alternative Medicine 2014 (2014): 1–16. http://dx.doi.org/10.1155/2014/753856.

Повний текст джерела
Анотація:
Background. Miscarriage is a very common complication during early pregnancy. So far, clinical therapies have limitation in preventing the early pregnancy loss. Chinese Medicine, regarded as gentle, effective, and safe, has become popular and common as a complementary and alternative treatment for miscarriages. However, the evidence to support its therapeutic efficacy and safety is still very limited.Objectives and Methods. To summarize the clinical application of Chinese Medicine for pregnancy and provide scientific evidence on the efficacy and safety of Chinese medicines for miscarriage, we located all the relevant pieces of literature on the clinical applications of Chinese Medicine for miscarriage and worked out this systematic review.Results. 339,792 pieces of literature were identified, but no placebo was included and only few studies were selected for systematic review and conducted for meta-analysis. A combination of Chinese medicines and Western medicines was more effective than Chinese medicines alone. No specific safety problem was reported, but potential adverse events by certain medicines were identified.Conclusions. Studies vary considerably in design, interventions, and outcome measures; therefore conclusive results remain elusive. Large scales of randomized controlled trials and more scientific evidences are still necessary to confirm the efficacy and safety of Chinese medicines during early pregnancy.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Medicine, Chinese"

1

Hsu, E. L. "Chinese medicine." Thesis, University of Cambridge, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.604684.

Повний текст джерела
Анотація:
This thesis explores ways in which the style of transmission is related to the contents of knowledge and practice. Chinese medicine has been legitimised and promoted by the government since the 1950s. Its transmission in government units is modelled on that of Western biomedicine. By analysing textbooks, I show ways in which, over the past thirty years, an attempt has been made to standardise the different strands of Chinese medical knowledge, and I refer to it as 'standardised knowledge'. This textbook knowledge conforms to Western biomedical systematisation, a materialist and static view of processes, and the ideology of Marxist dialectics. In settings outside the government work units Chinese therapeutic knowledge and practice has also been modified by Western thought and medicine, but not as systematically. Here, one still finds ways of learning which depend on the personal quality in the relationship between master and disciple. And here, the transmission of Chinese therapeutic knowledge is often veiled in secrecy. The comparison of these different tastes of knowing and healing aims to put the present standardisation of Chinese medicine into context and by highlighting qualities of knowing and healing in other settings of Chinese therapeutics, it points to the limitations of standardising medical knowledge and practice. Chapter One contributes to topics such as Socialist work units (danwei), post-Mao higher education, and curricula in Traditional Chinese Medicine (TCM). Chapter Two discusses a 'senior doctor's (laozhongyi) understanding of notions such as Experience (jingyan) and 'science' (kexue). Chapter Three contains case histories of qigong healing, and deals with topics such as voluntary associations and secrecy. Chapter Four contains a translation of Suwen 43 'On Obstructions' and discusses concepts of illness in qigong healing and Chinese medicine, with particular emphasis on Breath (qi). Chapter Five contains a translation of parts of Suwen 66 'The Rules of the Origins of Heaven' and discusses interpretations of concepts such as Change (bain, hua) and the Spirits (shen). Chapter Six discusses the textbook TCM Fundamentals and its precursors, and highlights how the understanding of concepts discussed in previous chapters has recently been transformed.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Phan, Tyler. "American Chinese medicine." Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1571107/.

Повний текст джерела
Анотація:
This thesis explores the power structures which shape Chinese medicine in the United States. Chinese medicine had two incarnations: migrant Chinese practice and its professionalized form. From the 1880s to the 1940s, Chinese medicine was practiced by the Chinese diaspora to serve their communities and non-Chinese settler populations. From the 1970s onward, Chinese medicine professionalized under the agency of acupuncture. Through the regulation of acupuncture, groups of predominately white Americans began to create standards of practice based on the enactment of what I have referred to as “orientalized biopower.” Orientalized biopower is the process where America’s predominately white counterculture began to encompass an orientalism which romanticized a form of Chinese medicine constructed in the 1950s by the People’s Republic of China called Traditional Chinese medicine (TCM). With the adoption of TCM in the United States, they also formulated measures which marginalized Asian Americans practitioners. The profession then labelled itself as “Oriental Medicine” embodying Edward Said’s concept of Orientalism. Along with this form of orientalism, the counterculture used the State to push for a standardized epistemology of TCM. In return, the State encompassed standardized Chinese medicine as element of biopower. My research is informed by a cross-country ethnography of schools, regulatory bodies, and private practices around North America. Through my investigation, I discover the power structures of Chinese medicine, contained within the regulatory bodies and schools, are mostly dominated by white Americans. Combined, they construct a profession and determine the “legitimate” and “illegitimate” forms of Chinese medicine, which constitutes the criteria for who can and cannot practice legally in the country.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Silberman, Tamar. "Chinese medicine meets American sensibilities: The use of Chinese medicine in the treatment of chronic conditions." Diss., Connect to online resource, 2006. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:1433475.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Chau, Ka-yee. "Health status of Chinese medicine users." View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36887110.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Chau, Ka-yee, and 周嘉儀. "Health status of Chinese medicine users." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B39723938.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Sun, Lizhe. "Value creation through modernizing Chinese medicine." Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/42217.

Повний текст джерела
Анотація:
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2007.
Includes bibliographical references (leaves 110-114).
My first hypothesis in this thesis is that there is significant value vested in traditional Chinese medicine that can be captured by converting them into ethical drugs through scientific analysis, screening and validation. Further, holistic treatment is a key difference between traditional Chinese medicine and western-type chemical drugs, which makes Chinese medicine a very valuable category of knowledge. Using mixed formula is a primary method of treatment in Chinese medicine. It is the application of distinctive medical philosophies of Chinese herbal medicines in practices, reflecting the uniqueness and advantages of Chinese medicine. For example, there are 96,592 mixed formula recorded by "Dictionary of Chinese Medicine Mixed Formula" published in 1997. My second hypothesis in this thesis is that value can be created and captured, under the globalization context, from mixed herbal formulas for the mainstream world market with the aid of fingerprint technologies. To enter western markets as officially approved drugs through critical pathways, both scientific and regulatory, Chinese herb drugs must demonstrate sound evidence for safety and efficacy. I address in this thesis one of the central concerns of the pharmaceutical companies and FDA, that is, how quality control and material consistency is assured and how toxicity and drug kinetics of Chinese herbal medicines, either in its raw form, its purified form, its composite extract form or its mixed formula form, may be measured with reasonable scientific certainty and what would be the likely trajectory of further research.
(cont.) My thesis research involves the following aspects: firstly, I characterize, by and through historical review and analysis, the formation of unique Chinese holistic medical philosophy to apply herbal medicines, particularly mixed herbal formulas, to systematically modulate the human body to prevent illnesses, to combat health problems and to restore balanced health; secondly, I performed a comparative study on the regulatory systems between Chinese SFDA and US FDA to provide insights on the trend of harmonic convergence of laws and regulations and challenges going forward, including collection and extrapolation of relevant statistical data; thirdly, I researched emerging fingerprint technologies to address the central issues of standardization, quality control, material consistency, safety and efficacy measurements of Chinese herbal medicines; fourthly, I performed data collection on major Chinese sources of published literatures and patent applications/grants for public and private medicinal knowledge formation, which may be viewed as a surrogate indicator for embedded economic value in the system, to compare trend and gaps between China and developed countries; and lastly, I presented three case studies of development of an-diabetic drugs from herbal sources, to illustrate how value may be created and captured through using modern technologies to tap into the accumulative knowledge base in herbal medicine. The thesis concludes that there are significant values to be captured, by and through cross-border collaborations under the globalization context, from Chinese herbal medicine. Both ethical single molecular entity (singleton) herb-derived drugs and mixed formula herb-derived drugs may be created going forward.
by Lizhe Sun.
S.M.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Lewis, Taylor Gabrielle, and Taylor Gabrielle Lewis. "Infertility Treatment and Traditional Chinese Medicine." Thesis, The University of Arizona, 2017. http://hdl.handle.net/10150/625038.

Повний текст джерела
Анотація:
Infertility treatments are sought after by about one in every ten women in the United States. In vitro fertilization (IVF) and intra-uterine insemination (IUI) are both relatively expensive and time consuming fertility options for patients and yet still cannot guarantee pregnancy will be achieved. Incorporating acupuncture into an IVF cycle creates a sympathoinhibitory effects, decreases pulsatillity index, and promotes increased uterine artery blood flow and therefore increased endometrial thickness and increased likelihood of embryo implantation. Additionally, acupuncture normalizes hypothalamic-pituitary-ovarian axis dysfunction. Incorporating Chinese herbal medicine (CHM) into an IVF cycle promotes estrogenic effects including uterine support through the luteal phase. Incorporating CHM into an IUI regimen helps to alleviate the anti-estrogenic effects of the follicle stimulating pharmaceuticals prescribed. In randomized trials, acupuncture and CHM significantly increased endometrial thickness measurements and CHM significantly increased pregnancy and live birth rates when used alongside IVF. Most patients have negative perceptions regarding traditional Chinese medicine and are therefore not receptive to using it or incorporating it into their fertility treatment plan. Because some positive effects and no negative effects have been found, physicians should continue to recommend these complementary approaches to their patients, provided the addition of TCM is financially feasible for the patient.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Cheng, Chung Wah. "Chinese herbal medicine for functional constipation." HKBU Institutional Repository, 2009. http://repository.hkbu.edu.hk/etd_ra/1090.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Zhan, Mei. "The worlding of traditional Chinese medicine a translocal study of knowledge, identity, and cultural politics in China and the United States /." online access from Digital dissertation consortium, 2002. http://libweb.cityu.edu.hk/cgi-bin/er/db/ddcdiss.pl?3067989.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Taylor, Kim. "Medicine of revolution : Chinese medicine in early communist China (1945-1963)." Thesis, University of Cambridge, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.621925.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Medicine, Chinese"

1

Duo, Gao, and Bernie Barbara, eds. Chinese medicine. New York, NY: Thunder's Mouth Press, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Manfred, Porkert, ed. Chinese medicine. New York: Morrow, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Christian, Ullmann, and Porkert Manfred, eds. Chinese medicine. New York: H. Holt, 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Giovanni, Maciocia, and Maciocia Giovanni, eds. Chinese medicine. New York: Churchill Livingstone, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

U, Unschuld Paul. Chinese medicine. Brookline, Mass: Paradign Publications, 1998.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Adams, James D., and Eric J. Lien, eds. Traditional Chinese Medicine. Cambridge: Royal Society of Chemistry, 2013. http://dx.doi.org/10.1039/9781849737852.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ody, Penelope. Practical Chinese medicine. London: Godsfield, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

McNamara, Sheila. Traditional Chinese medicine. New York: BasicBooks, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Liao, Yuqun. Traditional Chinese medicine. [Beijing]: China Intercontinental Press, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

P, Reid Daniel. Chinese herbal medicine. Boston: Shambhala, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Medicine, Chinese"

1

Zhang, David D. "Biometrics Chinese Medicine." In Automated Biometrics, 289–311. Boston, MA: Springer US, 2000. http://dx.doi.org/10.1007/978-1-4615-4519-4_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Heller, Lois Jane, Celette Sugg Skinner, A. Janet Tomiyama, Elissa S. Epel, Peter A. Hall, Julia Allan, Lara LaCaille, et al. "Traditional Chinese Medicine." In Encyclopedia of Behavioral Medicine, 1986. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_101805.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Sharpton, Amy N. "Traditional Chinese Medicine." In Encyclopedia of Immigrant Health, 1428–30. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5659-0_767.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Lao, Lixing, Ling Xu, and Shifen Xu. "Traditional Chinese Medicine." In Integrative Pediatric Oncology, 125–35. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-04201-0_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Yu, Cecilia, and Bob Yang. "Traditional Chinese Medicine." In Female Urinary Tract Infections in Clinical Practice, 61–67. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-27909-7_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Liu, Zhanwen. "Chinese Medicine Methodology." In Essentials of Chinese Medicine, 33–48. London: Springer London, 2009. http://dx.doi.org/10.1007/978-1-84882-590-1_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Liu, Zhanwen. "Chinese Medicine Methodology." In Essentials of Chinese Medicine, 33–48. London: Springer London, 2010. http://dx.doi.org/10.1007/978-1-84882-112-5_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Feng, Qiushi, Benlu Xin, and Danan Gu. "Traditional Chinese Medicine." In Encyclopedia of Gerontology and Population Aging, 1–7. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-69892-2_924-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Hsu, Elisabeth. "Traditional Chinese medicine." In The Routledge Handbook of Religion, Medicine, and Health, 126–40. London: Routledge, 2021. http://dx.doi.org/10.4324/9781315207964-11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Feng, Qiushi, Benlu Xin, and Danan Gu. "Traditional Chinese Medicine." In Encyclopedia of Gerontology and Population Aging, 5190–96. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-22009-9_924.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Medicine, Chinese"

1

Liu, Song-Hao. "Chinese medicine in new century and the research on Photonic Chinese Medicine." In 2008 International Conference on Technology and Applications in Biomedicine (ITAB). IEEE, 2008. http://dx.doi.org/10.1109/itab.2008.4570503.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Li, Chuan, Changjie Tang, Chunqiu Zeng, Jiang Wu, Yu Chen, Jiangtao Qiu, Li Dai, Jun Zhu, and Yongguang Jiang. "Discovering Multi-dimensional Major Medicines from Traditional Chinese Medicine Prescriptions." In 2008 International Conference on Biomedical Engineering And Informatics (BMEI). IEEE, 2008. http://dx.doi.org/10.1109/bmei.2008.244.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Wang, Yumei. "Research on Chinese Medicine Honeysuckle Medicinal Ingredients and Pharmacological Effects." In 2017 7th International Conference on Applied Science, Engineering and Technology (ICASET 2017). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/icaset-17.2017.8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Chen, Yujia, Yifeng Peng, Leiqi Wang, Yuanyu Zhang, and Tao Zhu. "Cyber-Enabled Traditional Chinese Medicine." In 2016 IEEE International Conference on Internet of Things (iThings) and IEEE Green Computing and Communications (GreenCom) and IEEE Cyber, Physical and Social Computing (CPSCom) and IEEE Smart Data (SmartData). IEEE, 2016. http://dx.doi.org/10.1109/ithings-greencom-cpscom-smartdata.2016.106.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Wang, Tongyuan, Bipin C. Desai, Huzhan Zheng, and Yanjiang Qiao. "Knowledge discovery in Chinese medicine." In the 2008 C3S2E conference. New York, New York, USA: ACM Press, 2008. http://dx.doi.org/10.1145/1370256.1370273.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Chen, Sushing, Bairong Shen, Jiajia Chen, Yang Yang, and Yuan Li. "Traditional Chinese Medicine data mining: Associating clinical cancer case studies with Traditional Chinese Medicine therapies." In 2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW). IEEE, 2010. http://dx.doi.org/10.1109/bibmw.2010.5703879.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Guang Zheng, Junping Zhan, Hongtao Guo, Miao Jiang, Cheng Lu, and Aiping Lu. "Rule-based text mining of traditional Chinese medicine patterns with Chinese herbal medicines and symptoms on cirrhosis." In 2012 International Symposium on Information Technology in Medicine and Education (ITME 2012). IEEE, 2012. http://dx.doi.org/10.1109/itime.2012.6291368.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Feng, Yi, Zhaohui Wu, Huajun Chen, Tong Yu, Yuxin Mao, and Xiaohong Jiang. "Data Quality in Traditional Chinese Medicine." In 2008 International Conference on Biomedical Engineering And Informatics (BMEI). IEEE, 2008. http://dx.doi.org/10.1109/bmei.2008.268.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Xiaofang, Zhou, Li Xue, Hu Yangyang, Zhang Wenqiang, and Li Fufeng. "Lip analysis in traditional Chinese medicine." In 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2017. http://dx.doi.org/10.1109/bibm.2017.8217864.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Liu, Songhao, Timon C. Liu, Yan Li, and Yao-Yong Meng. "Introduction to photon traditional Chinese medicine." In Optics and Optoelectronic Inspection and Control: Techniques, Applications, and Instruments, edited by Hong Liu and Qingming Luo. SPIE, 2000. http://dx.doi.org/10.1117/12.403969.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Medicine, Chinese"

1

Li, Rongchao. NiuHuangNingGongPian (Traditional Chinese medicine) for schizophrenia (Review). INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2023. http://dx.doi.org/10.37766/inplasy2023.11.0060.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gao, Yicheng, Rui Cao, Zhihan Liu, Meijun Liu, Yidi Liao, Yuting Feng, Xinmiao Gaun, et al. The structure and expression of clinical questions in guidelines for most traditional Chinese medicine were poor standardized: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2023. http://dx.doi.org/10.37766/inplasy2023.4.0064.

Повний текст джерела
Анотація:
Review question / Objective: To systematically investigate the clinical question reporting of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) clinical practice guidelines (CPGs) and traditional Chinese medicine (TCM) CPGs. Eligibility criteria: The inclusion of TCM CPGs adopts the following approach: 15 CPGs were randomly selected from six authoritative Chinese medicine societies (China Association of Chinese Medicine, China Association of Traditional Chinese Medicine, Chinese Association of Integrative Medicine, China Association for Acupuncture and Moxibustion, World federation of Chinese medicine societies, Doctor Society of integrative Medicine, Chinese Medical Doctor Association) and guidelines published by other societies, less than 15 are included. We discarded older versions and duplicate published guidelines.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Cui, Zhaorui, Yahui Wang, and Yanchen Zhu. Chinese herbal medicine for catheter ablation of atrial fibrillation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0096.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Zheng, You-you, Ning Liang, Long-kun Liu, Wei-jia Sun, Xue-hui Wang, Yu-xin Sun, Yun-ru Chen, Xiao-xia Han, Zhao-lan Liu, and Jian-ping Liu. Effectiveness and Safety of Chinese Patent Medicine for Functional Constipation: A Systematic Review and Network-Meta Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0049.

Повний текст джерела
Анотація:
Review question / Objective: To evaluate the effectiveness and safety of Chinese patent medicine in treatment of functional constipation by using the Network Meta-Analysis. 1. Types of participants: participants diagnosed as functional constipation according to Rome III, Rome IV or other published criteria or guidelines. No limitation on types of FC, age, sex, and nation. Children and pregnant women were excluded. Participants who had other constipation-related diseases including irritable bowel syndrome, functional defecation disorders and opioid-induced constipation were excluded. 2 Types of Interventions. Chinese patent medicine which have been registered with the approval batch number beginning with “Z,” approved by Chinese National Medical Product Administration (NMPA), used alone or in combination with Polyethylene Glycol, Lactulose, Bisacodyl, Prucalopride Succinate, probiotic, or Mosapride which recommended by latest clinical guidelines released by authorized organizations. The dosage, formulation, and route of administration of Chinese patent medicine were not limited. 3 Types of control. Registered Chinese patent medicines used alone, Polyethylene Glycol, Lactulose, Bisacodyl, Prucalopride Succinate, probiotic, Mosapride which recommended by latest clinical guidelines released by authorized organizations or placebo were eligible. 4 Types of outcomes. Primary outcomes were the clinical effect, score of dyschezia and defecation time. Secondary outcomes were adverse events and recurrence rate. 5 Types of study design. Parallel randomized controlled trials (RCTs) were included. Conference abstracts were excluded if full articles were not available.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Zhang, Yinzhen, Yanpeng wang, Wenjun Cai, Changwei Zhao, and Wenhai Zhao. Chinese Knee Osteoarthritis population and Traditional Chinese Medicine Constitution: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0074.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Yin, Sili, Zheng Liu, XiuHan Chen, Qianchen Liu, and Hua Lu. Efficacy of traditional Chinese medicine enema for pelvic inflammatory mass. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2023. http://dx.doi.org/10.37766/inplasy2023.5.0055.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Liu, Yuxin, Shuangqing Zhai, Xiuchao Liu, and Jintao Liu. Traditional Chinese medicine therapies for cervical spondylotic radiculopathy: A protocol for Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0114.

Повний текст джерела
Анотація:
Review question / Objective: P: Patients diagnosed with cervical spondylotic radiculopathy (CSR). I: The treatmen group will be treated with traditional Chinese medicine therapies (with/without additional treatment) including acupuncture of several types (acupuncture, acupoint sticking, acupoint injection, electroacupuncture and so on), massage, cervical traction, fire needle, traditional Chinese medicine hot compress, or their combination. No restrictions are imposed on length of the treatment period, times of treatment, and frequency of treatment. C: The traditional Chinese medicine therapies (with/without additional treatment) including acupuncture of several types (acupuncture, acupoint sticking, acupoint injection, electroacupuncture and so on), massage, cervical traction, fire needle, traditional Chinese medicine hot compress, or their combination will be included in this review. S: Only randomized controlled trials (RCTs) will be included.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Jiang, Yuchang, Mao Zhao, Zhipeng Fan, Zaili Gan, and Yong Jiang. Traditional Chinese Medicine for Primary hypothyroidism: A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0035.

Повний текст джерела
Анотація:
Review question / Objective: The purpose of this study was to analyze the effect of Traditional Chinese Medicine on Primary hypothyroidism, and to provide evidence for the treatment of Primary hypothyroidism with Traditional Chinese Medicine. Condition being studied: Primary hypothyroidism is a systemic hypometabolic syndrome in which TH deficiency or TH resistance is caused by the disease of the thyroid itself. TH replacement therapy, internationally recognized as the most effective treatment, has many disadvantages. Studies have shown that Traditional Chinese Medicine can effectively eliminate the symptoms of hypothyroidism and improve thyroid secretion. However, the validity of the results was low due to study limitations. Therefore, it is necessary to conduct a systematic analysis of randomized controlled trials of Traditional Chinese Medicine for Primary hypothyroidism.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Zheng, Ruo-xiang, Jia-wei Xu, Bi-yao Jiang, Wei Tang, Chun-li Lu, Xiao-yang Hu, and Jian-ping Liu. Mind-body therapies in traditional Chinese medicine for neuropathic pain: a systematic review of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0016.

Повний текст джерела
Анотація:
Review question / Objective: The purpose of this review is to comprehensively evaluate the effectiveness and safety on mind-body therapies of traditional Chinese medicine for neuropathic pain. Condition being studied: According to the definition by the International Association for the Study of Pain (IASP), neuropathic pain is a kind of pain caused by lesions or diseases affecting the somatosensory nervous system. It has brought considerable negative impacts on patients and society. Neuropathic pain is a prevalent disease and can be induced by a variety of clinical conditions such as spinal cord injury (prevalence rate: 53%), induced peripheral neuropathic pain (prevalence rate: 38%), diabetic peripheral neuropathic pain (prevalence rate: 10%-26%), chemotherapy postherpetic neuralgia (3.9-42.0/10,000 people per year), prosopalgia (3-5/10,000 people per year), and so on. However, current recommended medicines for neuropathic pain management could cause dependence and adverse events. Thus, alternatives would be helpful for both patients and clinicians. Mind-body therapy in traditional Chinese medicine (TCM) has a long history in clinical practice for relieving pain and their effectiveness has not been systematically reviewed.The purpose of this review is to comprehensively evaluate the effectiveness and safety on mind-body therapies of traditional Chinese medicine for neuropathic pain.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Wu, Junsong, Xuefeng Liu, Hejing Liu, Yang Wang, Zhili Xiong, Minyi Shen, and Kun Zhong. Chinese Herbal Medicine Combined with Acupuncture-related therapy as Complementary Therapies for Diabetic Nephropathy: A Protocol for Systematic Review and Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0095.

Повний текст джерела
Анотація:
Review question / Objective: Evaluating the efficacy of various Chinese herbal medicines combined with acupuncture-related therapies in the treatment of diabetic nephropathy. Information sources: We will search the following databases for relevant randomised controlled trials: PubMed, EMBASE, Cochrane Library, Scopus, OVID,Web of Science, Cochrane Central Register of Controlled Trials, China Biology Medicine (CBM), the China National Knowledge Infrastructure (CNKI), Wanfang data, and the Chinese Scientifific Journal Database (VIP). Search until April 10, 2022, with a combination of MeSH terms and free words.
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Medicine, Chinese" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії